Advances in the Prevention and Treatment of Liver Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 30 June 2025 | Viewed by 6564
Special Issue Editor
Special Issue Information
Dear Colleagues,
Advances in the prevention and treatment of liver cancer have made significant strides in recent years. New screening techniques, such as enhanced imaging and biomarker tests, have improved early detection, allowing for timely intervention. Minimally invasive procedures, like radiofrequency ablation and transarterial chemoembolization, have become more effective alternatives to traditional surgery.
Innovations in targeted therapies and immunotherapies, like sorafenib and checkpoint inhibitors, have expanded treatment options for advanced cases. Personalized medicine approaches, guided by genetic profiling, help tailor treatments to individual patients, optimizing outcomes and reducing side effects.
Prevention efforts have emphasized the importance of reducing risk factors such as hepatitis B and C infections, excessive alcohol consumption, and obesity. Vaccination against hepatitis B has been a crucial tool in decreasing liver cancer incidence. Public health campaigns promoting lifestyle changes and regular screenings have contributed to better liver cancer outcomes globally.
Dr. Ewa Janczewska
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- new screening techniques
- enhanced imaging
- biomarker tests
- radiofrequency ablation
- transarterial chemoembolization
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.